Originally developed in the context of glucose regulation, it is now widely referenced in research exploring appetite signaling, energy balance, and broader cardiometabolic processes, including interactions between the brain, pancreas, and digestive system
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is a GLP-1 receptor agonist widely prescribed for type 2 diabetes and weight management
In the liver, glutathione binds to toxins before theyre excreted, which is an important step in getting them out of your body
Beyond general food preferences, GLP-1 RA therapy also appears to modulate sensory responses
Some people report feeling discouraged or defeated by needing to switch, particularly if cost or access barriers forced the change rather than it being their choice